Atlas Trials

A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis by Detecting CTCs

Clinical trial NCT02510781 · UNKNOWN

Trial details

NCT number
NCT02510781
Sponsor
Hospital Affiliated to Military Medical Science, Beijing
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Neoplasms
Start date
2015-01-01
Primary completion
2016-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.